Radiotherapeutic strategies in the management of hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37972813

about

Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis Concurrent chemoradiotherapy shows long-term survival after conversion from locally advanced to resectable hepatocellular carcinoma Liver cancer: Approaching a personalized care.Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma.Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma.Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07).Newer treatments for advanced hepatocellular carcinoma.Biomarker studies on radiotherapy to hepatocellular carcinoma.Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective study High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma.Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling.Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter?

P2860

Q26738533-516BA592-CE7C-4604-8660-B56D8C272333 Q34384265-7B16B307-A127-4612-AE45-7671496F9A03 Q35903794-6CC7E5BD-B23F-451D-922B-14BEA4FC5042 Q36537059-F9E1C183-EF1B-46B5-83A8-1BCC2E0E0B89 Q36561787-11CB3BBF-1262-42A1-8408-30651A46F7AB Q37061945-67B27111-F6B2-46CD-A301-395F37643F29 Q37140658-3FEF6DF2-85BC-4CE2-A8CF-598498B358ED Q37606632-F1EB0E2F-9CAC-40D8-A882-E79B3AA624E3 Q37642185-F8D6DE0E-F740-4806-BD83-7D0B2DA972F6 Q38083433-BE37941D-A219-4861-A1AC-16A007DDE05E Q41431029-E3A4416D-D662-48A5-8B46-23882D4E8A33 Q42199538-00FB8AB5-5A27-4135-B395-BA05D217DB9C Q49300596-527B0367-CE9F-418A-8792-04FE43D8E7F4 Q54918612-C2F1E8EB-12F8-4729-A38E-C3FF96315431

P2860

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37972813

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@en

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@nl

type

label

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@en

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@nl

prefLabel

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@en

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@nl

P1433

Q37972813-2D848CC5-877E-4006-8200-D6A5FF7042E7

P1476

Q37972813-6D0722A5-44BC-4C68-A024-4D66D91D969C

P2093

Q37972813-5AE681BC-6871-4B9A-82C6-12B1889004A9

Q37972813-AD386380-B0F2-48E4-8304-CF9BBD36BB8E

P2860

Q37972813-02372583-A2D4-4149-B0D3-2B72F989582E

Q37972813-074D1BCA-3A86-4A09-837D-BC9D38F82EC3

Q37972813-08AFC15D-6114-47E6-BFC3-6F0EE4C035F0

Q37972813-0DFCC335-CA24-429A-812F-E2F13906FB03

Q37972813-0E83C315-F1C7-482D-986C-0ACD7877B94D

Q37972813-126F7AF6-7D64-409F-9B2C-76CAE6C7C9A4

Q37972813-19DA287D-9B32-4DD2-8F34-7ABF5C250059

Q37972813-305B50A1-AA6E-4144-80F4-087C72179E65

Q37972813-352F58BD-04E3-4BD3-986B-0C5EA958F3B0

Q37972813-398B255E-0302-49DA-A8EE-EF89952DC2FB

P304

Q37972813-CE217E08-5A6F-49C0-AD94-6E5E511C2850

P31

Q37972813-EC7E4C3F-E6C4-4DA3-B2C1-48806AEA701B

P356

Q37972813-7CD21D47-49F6-4CEA-9AB5-8359DED8CD2F

P478

Q37972813-154D94D0-CE17-462B-830C-7EC0C8F4CCAD

P577

Q37972813-53B232F4-6EBF-4515-880E-887ABF7982CE

P698

Q37972813-3EE9A8BC-15F2-4C4E-A3C0-ADF7EDF4FE0F

P356

P1433

P1476

Radiotherapeutic strategies in the management of hepatocellular carcinoma.

@en

P2093

Ik Jae Lee

http://www.w3.org/2001/XMLSchema#string

Jinsil Seong

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sorafenib in advanced hepatocellular carcinoma

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.

P304

123-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000333275

http://www.w3.org/2001/XMLSchema#string

P478

81 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22212946

http://www.w3.org/2001/XMLSchema#string